DENISE MOORE: Open Payments
NPI 1144744822 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 19 payments from 11 companies in 2025. Trend: 2023 $434 · 2024 $354 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| Edwards Lifesciences Corporation | 2 | $62 |
| GlaxoSmithKline, LLC. | 2 | $62 |
| Lilly USA, LLC | 2 | $46 |
| Dexcom, Inc. | 2 | $36 |
| Abbott Laboratories | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Insmed, Inc. | 1 | $16 |
Products named: AIRSUPRA, SAPIEN 3 Ultra RESILIA, TRELEGY ELLIPTA, Dexcom G6 Transmitter, FARXIGA, FREESTYLE LIBRE 3, MOUNJARO, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
